drugset / Trial / NCT03764085
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.
RandomizedParallel-groupSingle-blindTreatment
Summary
This study evaluates the efficacy and safety of Rheosorbilact®, solution for infusion ("Yuria-Pharm" LLC), in comparison with Ringer's Lactate, solution for infusion, in a complex therapy of sepsis. Half of participants will receive Rheosorbilact® in complex therapy, while the other half will receive Ringer's Lactate in complex therapy.
Timeline
- Start
- 2016-12-06
- Primary completion
- 2019-12-11
- Completion
- 2019-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rheosorbilact® | Unknown | 600 ml | Intravenous |
| Subject | Rheosorbilact® | Unknown | 1000 ml | Intravenous |
| Comparator | Ringer's Lactate | Other / unclassified | 1000 ml | Intravenous |
| Comparator | Ringer's Lactate | Other / unclassified | 2500 ml | Intravenous |